NEW YORK (360Dx) – Qiagen said today that its QuantiFeron-TB Gold Plus (QFT-Plus) blood test for detecting latent tuberculosis infection has received US Food and Drug Administration approval.

Qiagen submitted the test to FDA in a pre-market approval supplement in late 2016, and the company said that it expects to begin marketing the assay in the US later this year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.